Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€5.75

€5.75

-3.360%
-0.2
-3.360%
€46.48
 
25.04.24 / Frankfurt WKN: A2JQN1 / Symbol: REPL / Name: Replimune Group / Stock / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Replimune Group Inc Stock

Heavy losses for Replimune Group Inc today as the stock fell by -€0.200 (-3.360%).
Currently there is a rather positive sentiment for Replimune Group Inc with 3 Buy predictions and 0 Sell predictions.
Based on the current price of 5.75 € the target price of 46 € shows a potential of 700.0% for Replimune Group Inc which would more than double the current price.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Replimune Group Inc stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Replimune Group Inc in the next few years

Pros
?
M***** P*******
?
C******** o* t** e**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-10-30

Eine erste Durchsicht der Finanzunterlagen der Replimune Group zeigt ein gemischtes Bild. Während einige Aspekte positiv aufgenommen werden können, deuten andere auf mögliche Herausforderungen hin, die das Unternehmen in Zukunft bewältigen muss.

Beginnen wir mit den Vorteilen in der Finanzsituation der Replimune Group. Das Unternehmen verfügt über ein beachtliches Kapital von 555 Millionen US-Dollar (Stand 2023), was bedeutet, dass es über ausreichende Ressourcen verfügt, um seine aktuellen Geschäftsaktivitäten zu unterstützen. Außerdem ist erfreulich, dass die Aktien des Unternehmens relativ stabil geblieben sind, mit einer geringen Änderung im Jahr, was auf eine stabile Anlegerbasis hindeutet.

Darüber hinaus verfügt die Replimune Group über eine erhebliche Menge an kurzfristigen Investitionen (436 Millionen US-Dollar) im Jahr 2023. Diese können in bar umgewandelt werden, falls das Unternehmen Liquidität benötigt, was seine finanzielle Flexibilität erheblich verbessert.

Comments

Prediction Buy
Perf. (%) -21.01%
Target price 12.047
Change
Ends at 06.12.24

Replimune Group, Inc. (NASDAQ: REPL) had its price target lowered by analysts at Barclays PLC from $50.00 to $13.00. They now have an "overweight" rating on the stock.
Ratings data for REPL provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -45.75%
Target price 48.615
Change
Ends at 08.11.24

Replimune Group, Inc. (NASDAQ: REPL) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $52.00 price target on the stock.
Ratings data for REPL provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -68.75%
Target price 46.476
Change
Ends at 01.08.24

Replimune Group, Inc. (NASDAQ: REPL) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $51.00 price target on the stock.
Ratings data for REPL provided by MarketBeat
Show more